Considered as a repressor of VEGF function in angiogenesis, VEGFR1 protein levels have been  reported to be decreased in the parietal cortex of AD patients and in the cortex of 10- to 11-month-old male APP/PS1 mice [11, 23, 79]. Here, APP is linked to Alzheimer disease.